244 related articles for article (PubMed ID: 3034572)
21. Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.
Hirochika H; Broker TR; Chow LT
J Virol; 1987 Aug; 61(8):2599-606. PubMed ID: 3037119
[TBL] [Abstract][Full Text] [Related]
22. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor.
Stenlund A; Botchan MR
Genes Dev; 1990 Jan; 4(1):123-36. PubMed ID: 2155158
[TBL] [Abstract][Full Text] [Related]
23. Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions.
Rabson MS; Yee C; Yang YC; Howley PM
J Virol; 1986 Nov; 60(2):626-34. PubMed ID: 3021996
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.
Cripe TP; Haugen TH; Turk JP; Tabatabai F; Schmid PG; Dürst M; Gissmann L; Roman A; Turek LP
EMBO J; 1987 Dec; 6(12):3745-53. PubMed ID: 2448139
[TBL] [Abstract][Full Text] [Related]
25. Evidence that the transcriptional trans-activating function of the bovine papillomavirus type 1 E2 gene is not required for viral DNA amplification in division-arrested cells.
Alderborn A; Jareborg N; Burnett S
J Gen Virol; 1992 Oct; 73 ( Pt 10)():2639-51. PubMed ID: 1328476
[TBL] [Abstract][Full Text] [Related]
26. Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein encoded by bovine papillomavirus type 1.
Sun S; Thorner L; Lentz M; MacPherson P; Botchan M
J Virol; 1990 Oct; 64(10):5093-105. PubMed ID: 2168988
[TBL] [Abstract][Full Text] [Related]
27. Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction.
Hurwitz DR; Hodges R; Drohan W; Sarver N
Nucleic Acids Res; 1987 Sep; 15(17):7137-53. PubMed ID: 2821493
[TBL] [Abstract][Full Text] [Related]
28. The E2 "gene" of bovine papillomavirus encodes an enhancer-binding protein.
Moskaluk C; Bastia D
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1215-8. PubMed ID: 3029771
[TBL] [Abstract][Full Text] [Related]
29. Sp1 is critical for basal and E2-transactivated transcription from the bovine papillomavirus type 1 P89 promoter.
Sandler AB; Baker CC; Spalholz BA
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():189-98. PubMed ID: 8627222
[TBL] [Abstract][Full Text] [Related]
30. Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1.
Spalholz BA; Byrne JC; Howley PM
J Virol; 1988 Sep; 62(9):3143-50. PubMed ID: 2841467
[TBL] [Abstract][Full Text] [Related]
31. Papillomavirus transforming functions.
Howley PM; Yang YC; Spalholz BA; Rabson MS
Ciba Found Symp; 1986; 120():39-52. PubMed ID: 3013525
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter.
Spalholz BA; Vande Pol SB; Howley PM
J Virol; 1991 Feb; 65(2):743-53. PubMed ID: 1846195
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product.
Phelps WC; Howley PM
J Virol; 1987 May; 61(5):1630-8. PubMed ID: 3033289
[TBL] [Abstract][Full Text] [Related]
34. Bovine papillomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation.
Lambert PF; Howley PM
J Virol; 1988 Nov; 62(11):4009-15. PubMed ID: 2845119
[TBL] [Abstract][Full Text] [Related]
35. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.
Gloss B; Bernard HU; Seedorf K; Klock G
EMBO J; 1987 Dec; 6(12):3735-43. PubMed ID: 2828035
[TBL] [Abstract][Full Text] [Related]
36. Several different upstream promoter elements can potentiate transactivation by the BPV-1 E2 protein.
Ham J; Dostatni N; Arnos F; Yaniv M
EMBO J; 1991 Oct; 10(10):2931-40. PubMed ID: 1655407
[TBL] [Abstract][Full Text] [Related]
37. Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation.
Haugen TH; Lace MJ; Ishiji T; Sameshima A; Anson JR; Turek LP
Virology; 2009 Jun; 389(1-2):82-90. PubMed ID: 19410271
[TBL] [Abstract][Full Text] [Related]
38. Multiple cooperative interactions constrain BPV-1 E2 dependent activation of transcription.
Sowden M; Harrison S; Ashfield R; Kingsman AJ; Kingsman SM
Nucleic Acids Res; 1989 Apr; 17(8):2959-72. PubMed ID: 2542891
[TBL] [Abstract][Full Text] [Related]
39. An enhanced epithelial response of a papillomavirus promoter to transcriptional activators.
Vance KW; Campo MS; Morgan IM
J Biol Chem; 1999 Sep; 274(39):27839-44. PubMed ID: 10488130
[TBL] [Abstract][Full Text] [Related]
40. Multiple cis-active elements in the long control region of bovine papillomavirus type 1 (BPV-1).
Harrison SM; Gearing KL; Kim SY; Kingsman AJ; Kingsman SM
Nucleic Acids Res; 1987 Dec; 15(24):10267-84. PubMed ID: 2827118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
